Health · Healthcare & Policy · 10 hrs ago
New prices for 1,364 cancer medicine formulations take effect in India
In India, revised price caps for 1,364 cancer medicine formulations took effect on November 9, 2026.
The National Pharmaceutical Pricing Authority set trade-margin limits for 137 anti-cancer drugs, following recommendations from a health ministry expert committee.
By November 8, 85 companies had reported new prices for formulations covering 121 drugs.
Prices fell by more than 50% for 679 brands, with the largest reported cut at 96.45%.
The government estimates the changes will save consumers about ₹3,540 crore each year.
Chemists and hospital pharmacies cannot charge more than the revised maximum price.
Consumers can check prices on medicine packs, through the Pharma Sahi Daam app or the NPPA website, and report overcharging through the Pharma Jan Samadhan portal or the NPPA helpline.
Revised maximum retail prices for 1,364 anti-cancer medicine formulations took effect in India on November 9, 2026.
The government estimates the price changes will save consumers ₹3,540.38 crore a year.
The National Pharmaceutical Pricing Authority capped trade margins on 137 anti-cancer drugs.
As of November 8, 85 pharmaceutical companies had reported revised prices across 121 drugs.
Price reductions of more than 50% were reported for 679 brands, with the largest cut at 96.45%.
- Who
- The National Pharmaceutical Pricing Authority set the trade-margin caps; 85 pharmaceutical companies reported revised prices.
- What
- Revised maximum retail prices took effect for 1,364 anti-cancer formulations. The changes are projected to save consumers ₹3,540.38 crore annually.
- When
- November 9, 2026.
- Where
- India.
- Why
- To reduce the prices of anti-cancer medicines by capping trade margins.
This story does not have two clearly opposing sides.
An expert committee submitted recommendations on trade margins for anti-cancer drugs.
85 pharmaceutical companies had reported revised prices for 1,364 formulations across 121 drugs.
The revised maximum retail prices took effect.
- Formulations with revised prices
- 1,364
- Projected annual consumer savings
- ₹3,540.38 crore
- Drugs with capped trade margins
- 137
- Companies reporting revised prices
- 85
- Largest reported price reduction
- 96.45%